SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial

In a double-blind, placebo-controlled trial (EudraCT identifier: 2006-001795-20), the standardised quality (SQ) house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet (ALK, Denmark) was investigated. The trial included 604 subjects, ≥14 years, with mild-moderate HDM allergic asthma. Subjects w...

Full description

Saved in:

Bibliographic Details
Published in:	Respiratory medicine Vol. 108; no. 10; pp. 1430 - 1437
Main Authors:	de Blay, F., Kuna, P., Prieto, L., Ginko, T., Seitzberg, D., Riis, B., Canonica, G.W.
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01.10.2014
Subjects:	Adult Animals Asthma Asthma - drug therapy Asthma - immunology Asthma quality of life Budesonide - administration & dosage Double-Blind Method Glucocorticoids - administration & dosage House dust mite Humans ICS reduction Pulmonary/Respiratory Pyroglyphidae - immunology Quality of Life SLIT-tablet Sublingual Immunotherapy - methods Surveys and Questionnaires Tablets - administration & dosage Treatment Outcome Asthma quality of life ICS reduction House dust mite SLIT-tablet Asthma
ISSN:	0954-6111, 1532-3064, 1532-3064
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!